Code of Federal Regulations · Section
§ 862.3645 — Neuroleptic Drugs Radioreceptor Assay Test System
21 C.F.R. § 862.3645
View:
(a) Identification. A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.
(b) Classification. Class II.
Authorizing Statute
-
Adulterated drugs and devices21 U.S.C. § 351